Doximity, Inc. (NASDAQ:DOCS) Stock Holdings Increased by Invesco Ltd.

Invesco Ltd. lifted its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 525.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,272,403 shares of the company's stock after acquiring an additional 1,068,849 shares during the period. Invesco Ltd. owned 0.68% of Doximity worth $67,934,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in DOCS. Global Retirement Partners LLC raised its holdings in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock valued at $29,000 after buying an additional 440 shares during the period. UMB Bank n.a. lifted its holdings in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC boosted its position in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares during the period. Optimum Investment Advisors purchased a new position in Doximity in the fourth quarter valued at about $43,000. Finally, Morse Asset Management Inc acquired a new position in shares of Doximity during the third quarter worth about $46,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Stock Performance

Shares of DOCS traded up $0.32 during mid-day trading on Friday, reaching $53.10. 1,941,624 shares of the company's stock traded hands, compared to its average volume of 1,983,816. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The business's 50-day moving average price is $62.97 and its 200-day moving average price is $55.74. The stock has a market capitalization of $9.91 billion, a P/E ratio of 53.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on DOCS shares. Piper Sandler upgraded Doximity from a "neutral" rating to an "overweight" rating and upped their price target for the stock from $31.00 to $78.00 in a report on Friday, February 7th. Leerink Partners upgraded Doximity from a "market perform" rating to an "outperform" rating and lifted their price objective for the stock from $60.00 to $90.00 in a report on Friday, February 7th. Truist Financial reduced their target price on Doximity from $65.00 to $58.00 and set a "hold" rating for the company in a research note on Thursday, April 10th. KeyCorp dropped their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday. Finally, Bank of America boosted their target price on shares of Doximity from $54.00 to $57.00 and gave the stock a "neutral" rating in a research report on Monday, January 6th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Doximity currently has a consensus rating of "Moderate Buy" and an average target price of $65.00.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 37.40% of the company's stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.